A Diagnostic Odyssey: Successfully Treated Cytomegalovirus-Induced Immunodeficiency with Tuberculosis Coinfection Presenting as Fever of Unknown Origin in a Young Male
Background: Fever of unknown origin (FUO) in tuberculosis-endemic regions presents a significant diagnostic challenge. This complexity is heightened when concurrent infections and immune dysregulation, such as that caused by cytomegalovirus (CMV), confound the clinical picture and mimic other immunodeficiency states. Case Presentation: A previously healthy 20-year-old Filipino male presented with a three-week history of intermittent fever, malaise, and left cervical lymphadenopathy. An extensive workup for common infectious, autoimmune and malignant causes was unrevealing. However, laboratory testing revealed CMV viremia (463 copies/mL) with CD4+ T cell lymphopenia (332 cells/μL), despite a negative HIV evaluation. An excisional lymph node biopsy confirmed rifampicin-sensitive Mycobacterium tuberculosis, while bacterial culture also yielded Enterobacter cloacae. The patient received sequential antibacterials, then two weeks of valganciclovir—resulting in CMV clearance (undetectable viral load) and CD4+ T cell recovery (661 cells/μL). A follow-up examination four months later confirmed sustained CMV clearance and normal CD4+ T cell count (695 cells/μL). Anti-tuberculosis therapy, complicated by a drug-induced rash but successfully rechallenged, was completed with excellent tolerance and full clinical recovery. Conclusion: This case illustrates the diagnostic complexity of FUO in endemic areas, highlighting how CMV-induced immunosuppression, even in immunocompetent individuals, can mimic HIV infection and predispose to opportunistic coinfection. Careful evaluation and thorough infectious workup were pivotal in achieving diagnostic clarity and therapeutic success.
References
[1]
Petersdorf, R.G. and Beeson, P.B. (1961) Fever of Unexplained Origin: Report on 100 Cases. Medicine, 40, 1-30. https://doi.org/10.1097/00005792-196102000-00001
[2]
Cunha, B.A., Hage, J.E. and Nouri, Y. (2011) Fever of Unknown Origin (FUO) in an Immunocompetent Adult Due to Cytomegalovirus (CMV) with Polyclonal Gammopathy. Infection, 40, 327-330. https://doi.org/10.1007/s15010-011-0191-8
Gupta, M. and Shorman, M. (2025) Cytomegalovirus Infections. StatPearls Publishing. https://www.ncbi.nlm.nih.gov/books/NBK459185/
[5]
Cunha, B.A. and Chawla, K. (2018) Fever of Unknown Origin (FUO): CMV Infectious Mononucleosis or Lymphoma? EuropeanJournalofClinicalMicrobiology&InfectiousDiseases, 37, 1373-1376. https://doi.org/10.1007/s10096-018-3262-2
[6]
Fornara, O., Odeberg, J., Khan, Z., Stragliotto, G., Peredo, I., Butler, L., et al. (2013) Human Cytomegalovirus Particles Directly Suppress CD4 T-Lymphocyte Activation and Proliferation. Immunobiology, 218, 1034-1040. https://doi.org/10.1016/j.imbio.2013.01.002
[7]
Chang, Y.Y., Kuo, S.C. and Ku, S.W. (2025) Detection of Cytomegalovirus in Severely Ill Patients with Intractable COVID-19; a Retrospective Study. BMCPublicHealth, 25, Article No. 2522. https://doi.org/10.1186/s12889-025-23753-6
[8]
Krenzlin, H., Corr, F., Ailani, D., Einheuser, P., Bukur, T., Rößler, T., et al. (2025) Cytomegalovirus-Induced Oncomodulation Drives Immune Escape in Glioblastoma. ScientificReports, 15, Article No. 25981. https://doi.org/10.1038/s41598-025-10107-w
[9]
Gredmark-Russ, S. and Söderberg-Nauclér, C. (2012) Dendritic Cell Biology in Human Cytomegalovirus Infection and the Clinical Consequences for Host Immunity and Pathology. Virulence, 3, 621-634. https://doi.org/10.4161/viru.22239
[10]
Prösch, S., Wendt, C.E.C., Reinke, P., Priemer, C., Oppert, M., Krüger, D.H., et al. (2000) A Novel Link between Stress and Human Cytomegalovirus (HCMV) Infection: Sympathetic Hyperactivity Stimulates HCMV Activation. Virology, 272, 357-365. https://doi.org/10.1006/viro.2000.0367
[11]
Zhang, W., Morris, A.B., Peek, E.V., Karadkhele, G., Robertson, J.M., Kissick, H.T., et al. (2021) CMV Status Drives Distinct Trajectories of CD4+ T Cell Differentiation. FrontiersinImmunology, 12, Article ID: 620386. https://doi.org/10.3389/fimmu.2021.620386
[12]
Gadoth, A., Ourfalian, K., Basnet, S., Kunzweiler, C., Bohn, R.L., Fülöp, T., et al. (2024) Potential Relationship between Cytomegalovirus and Immunosenescence: Evidence from Observational Studies. ReviewsinMedicalVirology, 34, e2560. https://doi.org/10.1002/rmv.2560
[13]
Park, G.E., Ki, H.K. and Ko, J. (2021) Impact of Antiviral Treatment on Long-Term Prognosis in Non-Immunocompromised Patients with CMV Reactivation. BMCInfectiousDiseases, 21, Article No. 414. https://doi.org/10.1186/s12879-021-06098-4
[14]
Bhide, M., Singh, O., Nasa, P. and Juneja, D. (2024) Cytomegalovirus Infection in Non-Immunocompromised Critically Ill Patients: A Management Perspective. WorldJournalofVirology, 13, Article No. 89135. https://doi.org/10.5501/wjv.v13.i1.89135
[15]
Foreman, T.W., Nelson, C.E., Kauffman, K.D., Lora, N.E., Vinhaes, C.L., Dorosky, D.E., et al. (2022) CD4 T Cells Are Rapidly Depleted from Tuberculosis Granulomas Following Acute SIV Co-Infection. CellReports, 39, Article ID: 110896. https://doi.org/10.1016/j.celrep.2022.110896
[16]
European Centre for Disease Prevention and Control (2011) Use of Interferon-gamma Release Assays in Support of TB Diagnosis. ECDC GUIDANCE. https://www.ecdc.europa.eu/sites/default/files/media/en/publications/Publications/1103_GUI_IGRA.pdf
[17]
Park, H., Kang, Y., Kim, Y.N., Park, S., Lim, J., Park, J.Y., et al. (2022) Predictors for False-Negative Interferon-Gamma Release Assay Results in Hemodialysis Patients with Latent Tuberculosis Infection. Diagnostics, 13, Article No. 88. https://doi.org/10.3390/diagnostics13010088
[18]
Anci, E., Braun, C., Marinosci, A., Rodieux, F., Midun, E., Torres, M., et al. (2021) Viral Infections and Cutaneous Drug-Related Eruptions. FrontiersinPharmacology, 11, Article ID: 586407. https://doi.org/10.3389/fphar.2020.586407